Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 61,218 shares at $7.30 ($416K) on 2022-01-07, disclosed to the SEC on 2022-01-11.
Open-market sale of $416k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 13,370 | $98K | 23.5% |
| 2 | $6.65 | 23,924 | $159K | 38.3% |
| 3 | $6.65 | 23,924 | $159K | 38.3% |
| Total | $6.79 avg | 61,218 | $416K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |
| JNCE | SELL | 2021-01-11 | $220K | — | Filing → |